1. Bloch-Michel H, Milhaud G, Coutris G, Waltzing P, Charret A, Morin Y, et al. [Long term treatment of osteoporosis with thyrocalcitonin. Apropos of 7 cases]. Revue du rhumatisme et des maladies osteo-articulaires. 1970;37(10):629–38.
2. Dambacher MA, Olah AJ, Guncaga J, Lentner C, Haas HG. [Metabolic rates and histological-morphometrical investigations in bones of patients with osteoporosis subjected to long-term application of calcitonin]. Acta endocrinologica Supplementum. 1971;152:87.
3. Jowsey J, Riggs BL, Goldsmith RS, Kelly PJ, Arnaud CD. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis. J Clin Endocrinol Metab. 1971;33(5):752–8.
4. Wallach S, Aloia J, Cohn S. Treatment of osteoporosis with calcitonin. Semin Drug Treat. 1972;2(1):21–5.
5. Black DM, Reiss TF, Nevitt MC, Cauley J, Karpf D, Cummings SR. Design of the fracture intervention trial. Osteoporos Int. 1993;3 Suppl 3:S29–39.